Drug Shortage Report for TARO-ROSUVASTATIN

Last updated on 2020-04-04 History
Report ID 102366
Drug Identification Number 02382679
Brand name TARO-ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-19
Estimated end date 2020-04-03
Actual end date 2020-04-03
Shortage status Resolved
Updated date 2020-04-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-04 English Compare
v2 2020-01-04 French Compare
v3 2020-01-28 English Compare
v4 2020-01-28 French Compare
v5 2020-02-02 English Compare
v6 2020-02-02 French Compare
v7 2020-02-24 English Compare
v8 2020-02-24 French Compare
v9 2020-03-20 English Compare
v10 2020-03-20 French Compare
v11 2020-04-03 English Compare
v12 2020-04-03 French Compare
v13 2020-04-04 English Compare

Showing 1 to 13 of 13